Human papillomavirus testing methods

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 8, 2003, Pages 940-945

  Hubbard, Roger A ^a  

^a Molecular Pathology Laboratory Network Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NUCLEIC ACID; PHOSPHORUS 32; PRIMER DNA; VIRUS DNA;

CONFERENCE PAPER; CONSENSUS SEQUENCE; DNA SEQUENCE; GENOTYPE; HUMAN; IN SITU HYBRIDIZATION; MOLECULAR BIOLOGY; NONHUMAN; NUCLEIC ACID HYBRIDIZATION; NUCLEIC ACID PROBE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; VERRUCA VULGARIS; VIRUS DETECTION; VIRUS GENOME; VIRUS LOAD; WART VIRUS; CLASSIFICATION; DIAGNOSTIC PROCEDURE; FEMALE; GENETICS; ISOLATION AND PURIFICATION; METHODOLOGY; PAPILLOMA VIRUS; PATHOLOGY; REVIEW; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0042674405     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975;98:503-517.
2. Schiffman MH, Bauer HM, Lorincz AT, et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol. 1991;29:573-577.
3. Schneider A, Kraus H, Schuhmann R, Gissmann L. Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer. 1985;35:443-448.
4. Caussy D, Orr W, Daya AD, Roth P, Reeves W, Rawls W. Evaluation of methods for detecting human papillomavirus deoxyribonucleotide sequences in clinical specimens. J Clin Microbiol. 1988;26:236-243.
5. Bekkers RL, Melchers WJ, Bulten J, et al. Localized distribution of human papillomavirus genotypes in the uterine cervix. Eur J Gynaecol Oncol. 2002;23: 203-206.
6. Ausubel FM. Short Protocols in Molecular Biology: A Compendium of Methods From Current Protocols in Molecular Biology. 4th ed. New York, NY: Wiley; 1999.
7. Huang CC, Qiu JT, Kashima ML, Kurman RJ, Wu TC. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol. 1998;11:971-977.
8. Schwarzacher T, Heslop-Harrison J. Practical In Situ Hybridization. New York, NY: Springer Verlag; 2000:xii, 203.
9. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001:3.
10. Saiki RK, Walsh PS, Levenson CH, Erlich HA. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A. 1989;86:6230-6234.
11. Chen B, Yin H, Dhurandhar N. Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers. Hum Pathol. 1994;25:920-923.
12. Monk BJ, Cook N, Ahn C, Vasilev SA, Berman ML, Wilczynski SP. Comparison of the polymerase chain reaction and Southern blot analysis in detecting and typing human papilloma virus deoxyribonucleic acid in tumors of the lower female genital tract. Diagn Mol Pathol. 1994;3:283-291.
13. Meyer T, Arndt R, Stockfleth E, Flammann HT, Wolf H, Reischl U. Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. Biotechniques. 1995;19:632-639.
14. Gibson UE, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996;6:995-1001.
15. Rady PL, Arany I, Hughes TK, Tyring SK. Type-specific primer-mediated direct sequencing of consensus primer-generated PCR amplicons of human papilloma viruses: a new approach for the simultaneous detection of multiple viral type infections. J Virol Methods. 1995;53:245-254.
16. Kalantari M, Karlsen F, Johansson B, Sigurjonsson T, Warleby B, Hagmar B. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol. 1997;28:899-904.
17. Zhao S, Lu S, Fei S. Detection of human papillomavirus in Chinese laryngeal carcinoma with digoxigenin labelled probe prepared by PCR [in Chinese]. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 1998;12:153-155.
18. Jacobs MV, Walboomers JM, van Beek J, et al. A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings. Br J Cancer. 1999;81:114-121.
19. Nindl I, Lotz B, Kuhne-Heid R, Endisch U, Schneider A. Distribution of 14 high risk HPV types in cervical intraepithelial neoplasia detected by a non-radioactive general primer PCR mediated enzyme immunoassay. J Clin Pathol. 1999; 52:17-22.
20. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357-361.
21. Stephen AL, Thompson CH, Tattersall MH, Cossart YE, Rose BR. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer. 2000;86:695-701.
22. Husnjak K, Grce M, Magdic L, Pavelic K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods. 2000;88:125-134.
23. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986-994.
24. HC2 [product insert]. Hybrid Capture 2 DNA Test, L0838 vol. Gaithersburg, Md; Digene Corp; 2002:49.
25. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst. 2000;92:397-402.
26. Belinson J, Qiao Y, Pretorius R, et al. Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study. Int J Gynecol Cancer. 1999;9:411-417.
27. Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer. 2001;84:1616-1623.
28. Gonzalez Sanchez JL, Chavez Brambila J, Hernandez Hernandez DM, Martinez Sanchez S, Garcia Carranca A. High and low risk human papilloma virus infection in women with CIN: differential characteristics [in Spanish]. Ginecol Obstet Mex. 2002;70:11-16.
29. Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA. 2000;283:87-93.
30. Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol. 2001;83:95-99.
31. Coutlee F, Gravitt P, Kornegay J, et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol. 2002;40:902-907.
32. Kado S, Kawamata Y, Shino Y, et al. Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers. Gynecol Oncol. 2001;81:47-52.
33. Karlsen F, Kalantari M, Jenkins A, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 1996;34:2095-2100.
34. Lungu O, Wright TC Jr, Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes. 1992;6:145-152.
35. Chow VT, Loh E, Yeo WM, Tan SY, Chan R. Identification of multiple genital HPV types and sequence variants by consensus and nested type-specific PCR coupled with cycle sequencing. Pathology. 2000;32:204-208.
36. Clavel C, Rihet S, Masure M, et al. DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR. J Clin Pathol. 1998;51:38-43.
37. Noffsinger AE, Suzuk L, Hui YZ, Gal AA, Fenoglio-Preiser CM. Differential sensitivities of E6 type-specific and L1 consensus primers in the detection of human papillomavirus in anal carcinoma. Mod Pathol. 1995;8:509-514.
38. Wang TS, Chou HF, Liu WM, Choo KB. Semiautomated typing of human papillomaviruses by restriction fragment length polymorphism analysis of fluorescence-labeled PCR fragments. J Med Virol. 1999;59:536-540.
39. Wang SY, Liu WM, Wang TS, Chou HF, Choo KB. Typing of human papillomaviruses by reductional RFLP analysis of biotin-labeled PCR fragments. Biotechniques. 1997;23:574-578.
40. Laconi S, Greco M, Milia G, et al. Simultaneous detection and typing of human papillomavirus in cervical biopsies using PCR-reverse hybridization [in Italian]. Pathologica. 2000;92:524-529.
41. Laconi S, Greco M, Pellegrini-Bettoli P, Rais M, Laconi E, Pani P. One-step detection and genotyping of human papillomavirus in cervical samples by reverse hybridization. Diagn Mol Pathol. 2001;10:200-206.
42. Perrons C, Kleter B, Jelley R, Jalal H, Quint W, Tedder R. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J Med Virol. 2002; 67:246-252.
43. Vernon SD, Unger ER, Williams D. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol. 2000;38:651-655.
44. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intraepithelial neoplasia and cervical cancer. Int J Cancer. 1999;82:203-207.
45. Feoli-Fonseca JC, Oligny LL, Brochu P, Simard P, Falconi S, Yotov WV. Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol. 2001;63:284-292.
46. Yamazaki H, Sasagawa T, Basha W, Segawa T, Inoue M. Hybrid capture-II and LCR-E7 PCR assays for HPV typing in cervical cytologic samples. Int J Cancer. 2001;94:222-227.
47. Bontkes HJ, van Duin M, de Gruijl TD, et al. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer. 1998;78:166-171.
48. Reesink-Peters N, Burger MP, Kleter B, Quint WG, Bossuyt PM, Adriaanse AH. Using a new HPV detection system in epidemiological research: change of views on cervical dyskaryosis? Eur J Obstet Gynecol Reprod Biol. 2001;98:199-204.
49. Manos MM, Waldman J, Zhang TY, et al. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis. 1994; 170:1096-1099.
50. Bekkers RL, Melchers WJ, Bakkers JM, et al. The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia. Int J Cancer. 2002;102:148-151.
51. Jacobs MV, Snijders PJ, Voorhorst FJ, et al. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol. 1999;52:498-503.
52. Nelson JH, Hawkins GA, Edlund K, et al. A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples. J Clin Microbiol. 2000;38:688-695.
53. Hart KW, Williams OM, Thelwell N, et al. Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples. J Clin Microbiol. 2001;39:3204-3212.
54. De Marco F, Di Carlo A, Poggiali F, Muller A, Marcante ML. Detection of HPV in genital condylomata: correlation between viral load and clinical outcome. J Exp Clin Cancer Res. 2001;20:377-383.
55. Josefsson AM, Magnusson PK, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355:2189-2193.
56. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol. 2002;40:886-891.
57. Sun CA, Liu JF, Wu DM, Nieh S, Yu CP, Chu TY. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet. 2002;76:41-47.
58. Zerbini M, Venturoli S, Cricca M, et al. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J Clin Pathol. 2001;54:377-380.
59. Bory JP, Cucherousset J, Lorenzato M, et al. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int J Cancer. 2002;102:519-525.
60. Howard M, Sellors J, Kaczorowski J. Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia. Obstet Gynecol. 2002;100:972-980.
61. Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 2002;360:228-229.
62. van Duin M, Snijders PJ, Schrijnemakers HF, et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer. 2002;98:590-595.
63. Garland SM. Human papillomavirus update with a particular focus on cervical disease. Pathology. 2002;34:213-224.
64. Moore CE, Wiatrak BJ, McClatchey KD, et al. High-risk human papillomavirus types and squamous cell carcinoma in patients with respiratory papillomas. Otolaryngol Head Neck Surg. 1999;120:698-705.
65. Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol. 2000;60:396-402.
66. Clavel CE, Nawrocki B, Bosseaux B, et al. Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer. 2000;88:1347-1352.
67. Hoffmann M, Kahn T, Mahnke CG, Goeroegh T, Lippert BM, Werner JA. Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta Otolaryngol. 1998; 118:138-144.
68. Williams OM, Hart KW, Wang EC, Gelder CM. Analysis of CD4(+) T-cell responses to human papillomavirus (HPV) type 11 L1 in healthy adults reveals a high degree of responsiveness and cross-reactivity with other HPV types. J Virol. 2002;76:7418-7429.
69. Zehbe I, Wilander E, Delius H, Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998;58:829-833.
70. Morrison EA, Ho GY, Vermund SH, et al. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer. 1991;49:6-13.
71. Becker TM, Wheeler CM, McGough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA. 1994;271:1181-1188.
72. Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet. 1999;354: 218-219.
73. Zehbe I, Voglino G, Wilander E, et al. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res. 2001;61:608-611.
74. Bowtell D, Sambrook J. DNA Microarrays: A Molecular Cloning Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2003:xxiii, 712.